Inappropriate cardiac remodeling and repair after myocardial infarction (MI) predisposes to heart failure. Studies have reported on the potential for lineage negative, steel factor positive (c-kit ؉ ) bone marrow-derived hematopoetic stem͞progenitor cells (HSPCs) to repair damaged myocardium through neovascularization and myogenesis. However, the precise contribution of the c-kit signaling pathway to the cardiac repair process has yet to be determined. In this study, we sought to directly elucidate the mechanistic contributions of c-kit ؉ bone marrow-derived hematopoetic stem͞ progenitor cells in the maintenance and repair of damaged myocardium after MI. Using c-kit-deficient mice, we demonstrate the importance of c-kit signaling in preventing ventricular dilation and hypertrophy, and the maintenance of cardiac function after MI in c-kit-deficient mice. Furthermore, we show phenotypic rescue of cardiac repair after MI of c-kit-deficient mice by bone marrow transplantation of wild-type HSPCs. The transplanted group also had reduced apoptosis and collagen deposition, along with an increase in neovascularization. To better understand the mechanisms underlying this phenotypic rescue, we investigated the gene expression pattern within the infarcted region by using microarray analysis. This analysis suggested activation of inflammatory pathways, specifically natural killer (NK) cell-mediated mobilization after MI in rescued hearts. This finding was confirmed by immunohistology and by using an NK blocker. Thus, our investigation revealed a previously uncharacterized role for c-kit signaling after infarction by mediating bone marrow-derived NK and angiogenic cell mobilization, which contributes to improved remodeling and cardiac function after MI.
C ardiovascular diseases are the leading cause of morbidity and mortality in the Western world. Prolonged periods of myocardial ischemia lead to extensive myocyte injury and extracellular matrix remodeling that, in turn, leads to ventricular dysfunction and heart failure (1) . Myocardial infarction (MI) is associated with an intense inflammatory response and activation of the host innate immune program for inflammatory cell mobilization and cardiac repair and remodeling (2, 3) . Recent data suggests that various types of lineage negative, c-kit positive (lin Ϫ c-kit ϩ ) bone marrow (BM)-derived cells, including hematopoetic stem͞progenitor cells and mesenchymal stem cells, can repair damaged myocardium after MI and improve cardiac remodeling (4) . In this context, it has been shown either by direct cell injection (5) or by inducing cell mobilization (6) (7) (8) that BM cells home to the site of injury, contribute to the local wound repair, and may eventually differentiate into new vessels and myocytes (5) (6) (7) (8) . Other studies have failed to confirm the latter observation (9, 10) but instead suggest a paracrine role of BM-derived cells to mediate repair (11, 12) . Although the ideal cell population to affect cardiac repair and the innate mechanisms mediating functional improvement after MI is still to be determined, we sought to clarify the role of c-kit signaling in the mobilization and homing of cells remote from the heart for repair.
The steel factor receptor (c-kit) is a member of the tyrosine kinase family of receptors and is activated by stem cell factor͞kit ligand. Ligand binding leads to receptor dimerization and activation of multiple downstream signaling pathways involved in target mobilization, antiapoptosis, and cell proliferation (13) (14) (15) . In addition, recent findings report a possible role for c-kit and fetal liver kinase (Flt3) signaling in the mobilization of innate immune cells such as natural killer (NK) cells in the setting of neoplastic growth (16) .
NK and dendritic cells are the innate immune system's early defense against foreign cells and autologous cells undergoing various forms of stress (17) . NK cell activation and deactivation are regulated by various membrane-bound receptors controlling cell lysis and cytokine or chemokine release (18) . c-kit has been reported to play a major role in NK cell production and mobilization. In the absence of c-kit, there is a deficiency in production and maturation of BM-derived NK cells, whereas reduced c-kit activity leads to a reduction of circulating NK cells (18) .
Using c-kit-deficient and littermate-matched wild-type (WT) mice, we examined the role of the c-kit receptor in cardiac remodeling and repair after MI. We observed a worsening in cardiac dilation and function in c-kit-deficient mice compared with WT controls mice. We also rescued the c-kit cardiac repair deficiency with WT BM transplantation and observed increased mobilization of angiogenic and NK cells after MI.
in W͞W v mice (Table 2 ). There was no difference among sham groups.
BM Transplantation with WT Cells Rescues Defective Cardiac Repair in
c-kit Mutants. WT BM transplanted (BMT) c-kit mutant mice rescued adverse cardiac remodeling and impaired cardiac function. Three months after irradiation and BMT with WT BM marked by EGFP provirus, 58 of 60 W͞W v transplanted mice survived and appeared well. Of these mice, 57 expressed demonstrable levels (Ͼ1%) of EGFP (ranging from 1.7% to 88.0% with a mean of 43.5 Ϯ 2.8%) in peripheral blood after 3 months. Thirty-five days after MI, cardiac function was analyzed in a similar fashion as described above. All of these parameters were significantly improved in BMT W͞W v versus untreated W͞W v ( Fig. 1 and Table 2 ), to levels comparable with those found in WT ( Fig. 1 A-I ). Transplantation of WT BM into W͞W v before MI prevented cardiac dilation and rescued worsening cardiac symptoms. There were no significant differences between sham-treated groups: W͞W v , WT, and BMT W͞W v (Fig. 1 ). There was no significant difference in flow analyses for CD4, CD8, CD19, Gr1, and CD11b, excluding either a significant rejection process or an exuberant T cell or B cell response.
Expression Analysis Highlights Critical c-kit Pathways in MI Recovery.
Gene expression profiling depicted tight clustering between individual samples (W͞W v -untreated and the BMT W͞W v -treated group) ( Fig. 2A) (Fig. 7 , which is published as supporting information on the PNAS web site). There were no observed differences in the rate of nuclear damage or apoptosis at day 35 after MI (data not shown). To analyze neoangiogenesis, Ki67
ϩ cells colocalized with CD31 demonstrated increased endothelial cell differentiation at the border zone of infarcted hearts at day 3 and 7 ( Fig. 3 A-G) . At day 35, the number of Ki67 ϩ cells decreased and there were no differences between the groups. However, there was a significant increase (P Ͻ 0.001) in the number of vessels in the WT and BMT W͞W v Monoclonal EGFP antibody staining was used to identify EGFP ϩ cell presence in the normal zone, border zone, and infarcted regions of the heart. EGFP ϩ expression was highest at day 3 and 7 after MI (30.7 Ϯ 3.5 cells and 91.7 Ϯ 8.6 cells, respectively). At these early time points, the EGFP ϩ cells were small in diameter and did not have mature endothelial or myocyte morphology. However, at day 35 after MI, we found EGFP ϩ BM-derived cells had contributed significantly to neovascularization (Fig. 4 A-C (Fig. 5 ). This level of Flt3L demonstrates a previously unreported level of increase in cardiac Flt3L expression after MI, which is, in turn, much more exaggerated in c-kit-deficient mice, suggesting a potential synergetic compensatory mechanism by Flt3L in c-kit-deficient W͞W v mice, reversible with BM transplantation.
Discussion
Clinical trials using BM-derived stem͞progenitor cells to improve cardiac function and remodeling after MI have attracted a lot of attention worldwide. Various groups have demonstrated the feasibility and reasonable safety of implanting these adult stem cells in injured myocardium (5) (6) (7) (8) . However, the magnitude and permanence of initial benefits observed are only being explored now in randomized trial settings (9) (10) (11) parable with the WT group. We have demonstrated that BM transplantion in these mice improved cardiac function, reduced apoptosis, increased angiogenesis, and increased BM-derived cell mobilization and NK activity at early time points after MI.
Antiapoptotic paracrine activity of c-kit receptor signaling has been attributed to up-regulation of AKT cytoprotective signaling in target cells (15, 20) . Activation of AKT may explain the greater survival of endothelial cells and myocytes observed in WT mice when compared with W͞W v mice. Infiltrating or resident progenitor c-kit positive cells may be contributing to this paracrine rescue signaling. Similar salutary findings have been observed by injecting AKT overexpressing mesenchymal stem cells into infarcted myocardium, leading to a reduction in infarct size (21) . Our findings of reduced apoptosis in BMT W͞W v mice are consistent with the paracrine role of mobilized cells (Fig. 7) .
We have also observed that WT BMT W͞W v mice demonstrated improved angiogenesis. A role for c-kit signaling in neovascularization may be expected (22) because 70% of BM-derived CD34 ϩ cells express the c-kit receptor (7, 23) . Immunohistochemical colocalization of Ki67, CD31, and vessel number (Fig. 3) demonstrated increased endothelial cell proliferation and neovascularization in the BMT-rescued mice, which is also supported by gene expression analysis (Table 1 ). An increase in mobilization and neovascularization genes (CXCR4, MMP9, and EPHRNB2) was confirmed with real-time PCR analysis (data not shown). Although our findings demonstrated improved angiogenesis in the post-MI rescued group, there were surprisingly fewer differentiated EGFP ϩ cells at 5 weeks, suggesting that other angiogenic mechanisms are also involved. This observation may be explained by the presence of c-kit ϩ cardiac progenitor cells reported in the heart undergoing neovascularization (24, 25) . These cells can also differentiate into unlabeled myocytes and, hence, were undetected by our techniques (24) . These findings are supported by long-term remodeling studies performed in our laboratory. Aging W͞W v mice (9-10 months old) lead to worsening heart function in sham and infarcted mice, suggesting the presence of c-kit ϩ cardiac progenitor cells and their role in cardiac remodeling (Fig. 8 , which is published as supporting information on the PNAS web site). This worsening of heart function may be explained by the c-kit deficient cardiac progenitor cells in W͞W v mice preventing cell differentiation during aging or after injury.
Most importantly, our findings indicate an important role for NK cell mobilization and activity in the myocardium of BMT-rescued W͞W v mice. The importance of c-kit and its ligand, stem cell factor, in NK cell development, survival, and expansion has been demonstrated in vivo (18) . Furthermore, the addition of stem cell factor or fetal liver kinase ligand (Flt3L) has been shown to promote NK cell differentiation from hematopoetic stem͞progenitor cells in vitro (26) . W͞W v and Flt3L null mice exhibit a reduction in number and cytotoxicity of NK cells, whereas heterozygous mutants have a reduction in the number of circulating NK cells (18, 26) . We have also confirmed these observations with flow analysis of NK cells in WT and c-kit-deficient mice after MI (Fig. 9 , which is published as supporting information on the PNAS web site). These results indicate the importance of c-kit and flt3 receptors in development and also mobilization of NK cells in to the circulation after MI. We believe that WT BM transplantation rescued NK cell number, mobilization, and activity in W͞W v mice and helped rescue the infarcted heart (Fig. 4 D-F) .
The exact role and activity of NK cells in the myocardium after MI requires further investigation. One possible role of NK cells may include crosstalk with dendritic cells stimulating cytokine and chemokine release, leading to a protective paracrine effect. Borg et al. (16) demonstrated increased dendritic cell activity in W͞W v mice, leading to improved NK crosstalk. Furthermore, by blocking c-kit activity while administering Flt3 ligand in WT mice, they were able to phenocopy the increase in NK mobilization and activity observed in W͞W v mice (16) . Flt3 receptor and ligand activity has also been further indicated in the production of NK cells (27) , and increased coexpression of Flt3L in W͞W v mice has been reported (28) . To investigate the role of Flt3L in our experiments, we measured the levels in W͞W v and BMT W͞W v cardiac tissue and found significantly greater Flt3L levels 35 days after MI. There was also a significant reduction in cardiac Flt3L levels in BMT W͞W v at baseline and after MI compared with W͞W v mice demonstrating a synergetic response to c-kit deficiency (Fig. 5) . Our results suggest that rescued W͞W v mice have undergone repaired BM NK cell development and maturation, and with greater cardiac Flt3L expression after MI, increased mobilization into circulation and homing to the heart. In addition, in separate experiments, we have demonstrated that W͞W v mice have significantly lower numbers of peripheral NK cells and an increase in dendritic cell mobilization after MI (see Fig. 9 ). Using NK antibody blockers, we found a 40% reduction in survival of W͞W v mice, indicating the profound dependence on the already-low level of NK cells in these c-kitdeficient mice (Fig. 6) .
We have demonstrated c-kit receptor's active role in mediating repair and remodeling after MI and in the maintenance of cardiac function. Further investigation into the paracrine role of NK cells is required and may lead to new therapeutic approaches for improving outcomes after myocardial infarction as part of an overall cardiac regeneration therapeutic strategy.
Materials and Methods
Animal Surgery and Cardiac Evaluation. W͞W v (WBB6F1-Kit w Kit wϪv ) mice are compound heterozygotes of a null c-kit mutation (W) and the W-viable (W v ) allele exhibiting reduced kinase activity and representing the most severe c-Kit mutants that survive gestation (14, 15) . W͞W v and WT (WBB6F1) mice were purchased from The Jackson Laboratory. An LV MI was created in 10-to 12-week-old male W͞W v and WT mice by ligation of the left anterior descending coronary artery, as described in refs. 29 and 30. In experiment 1, W͞W v (n ϭ 12) and WT mice (n ϭ 12) underwent coronary artery ligation and were monitored for morbidity and mortality. Sham operations (n ϭ 8, W͞W v ; and n ϭ 8, WT) were also performed as an operative control. At day 35, heart function was analyzed. In experiment 2, W͞W v (n ϭ 24) and WT (n ϭ 24) mice were randomized into sham-operated controls or infarction groups and randomized again for killing on days 3, 7, and 35 (n ϭ 6 per time point). Hearts were harvested, rinsed with PBS (GIBCO), frozen, and stored at Ϫ80°C until analysis. In experiment 3, BM from WT mice was extracted and transduced with a lentivirus that engineers expression of EGFP (31), transplanted into irradiated W͞W v mice, and allowed to reconstitute for 3 months. Mice were then randomized into sham (n ϭ 22) or infarcted groups (n ϭ 30), and hearts were collected at similar time points as in experiment 1 and 2. WT-to-WT (n ϭ 5) and W͞W v -to-W͞W v (n ϭ 5) BMT was also performed and served as controls. In experiment 4, WT (n ϭ 24) and W͞W v (n ϭ 26) mice were pretreated with a rabbit anti-mouse polyclonal NK blocker (Cedarlane Laboratory, Hornby, ON, Canada) and then randomized into MI or sham groups. These mice were monitored for survival. Cardiac function of all mice surviving until day 35 was analyzed by using a Millar pressure volume conductance catheter. Morphometrics, pathology, and collagen staining were analyzed as described in refs. 29 and 30. 5-fluorouracil (150 mg͞kg, Sigma). Four days later, BM cells from femoral and tibial bones were flushed and mononuclear cells (MNCs) isolated over a Nycoprep density gradient. BM MNCs were resuspended in DMEM (GIBCO) supplemented with 20% FCS (GIBCO)͞6 ng/ml murine IL-3͞10 ng/ml murine IL-6͞100 ng/ml murine stem cell factor (all from R & D Systems). Lentivector infections were performed with concentrated virus at a multiplicity of infection of 30 in the presence of 8 g͞ml protamine sulfate (Sigma) on fibronectin-coated (5 g͞cm 2 , Roche, Penzberg, Germany), nontissue culture-treated plates. After an overnight infection, adherent and nonadherent cells were harvested, washed, and resuspended in D-PBS. Approximately 1 ϫ 10 6 transduced cells were transplanted intravenously into W͞W v male mice that were preconditioned with 300 cGy (110 cGy͞min 37 Cs-rays by using Gamma Cell 40 from MBS Nordion) of total body irradiation. Peripheral blood from transplanted mice was collected from tail veins in K 2 EDTA tubes (BD Biosciences). RBCs were lysed with RBC lysis buffer (Sigma), and flow cytometric analyses for EGFP expression and CD4, CD8, CD19, Gra-1, and CD11b (all antibodies purchased from BD Biosciences) were performed by using a FACSCalibur (BD Biosciences).
Microarray Analysis by Using Affymetrix GeneChip Hybridization.
Total RNA was isolated from 18 heart samples by using TRIzol reagent (GIBCO͞BRL) and following the manufacturer's protocol. The quality of RNA was assessed by an Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies, Palo Alto, CA). A total of 18 hybridizations were performed on the MG-430 or 430-2 mouse GeneChip set (Affymetrix, Santa Clara, CA) with the 18 RNAs from the infarcted region of hearts (six different groups with three replicates per group: WT days 3 and 7, W͞W v days 3 and 7, and BMT W͞W v day 3 and 7). Samples were prepared for hybridization according to standard Affymetrix instructions and performed at the Toronto Genomic Core Centre at the Hospital for Sick Children. Experimental design, gene lists, hierarchical trees, chip hybridizations, and statistical analyses were done in compliance with the Minimum Information About a Microarray Experiment guidelines (32) .
Affymetrix GeneChip Data Analysis. To monitor gene expression over different time points, data obtained from the GCOS (GeneChip Operating Software) absolute analyses of all of the individual arrays were analyzed and clustered by using GENESPRING 7.0 (Agilent Technologies). After filtering, one-way ANOVA (nonequal variance) was performed and 2-fold up-or down-regulated genes in the BMT W͞W v vs. untransplanted W͞W v mice were used for hierarchical clustering. The up-or down-regulated genes in BMT W͞W v mice vs. both W͞W v and WT were used to generate the hypersensitive gene lists.
Immunohistochemistry and Collagen Content. Cryostat sections (5 m) were cut from day 3, 7, and 35 hearts, air-dried, and fixed in cold acetone (Ϫ20°C) for 10 min. The endogenous peroxidase activity was blocked by 0.3% hydrogen peroxide (Sigma) incubated for 30 min with 10% normal rabbit͞goat serum (GIBCO). Reaction with primary CD31 (BD Pharmingen), Ki67 (ID Labs, London, ON, Canada), anti-GFP (Abcam, Inc., Cambridge, MA), human von Willebrand factor VIII (Sigma), and CD94 (Biodesign International, Kennebunkport, ME) antibodies were performed overnight at 4°C and then labeled with the appropriate secondary fluorescent antibodies (Sigma). Quantification of immunoreactive cells (200 optical fields) was performed with the use of a Quantimet 600 image analysis system (Leica, Deerfield, IL) (29, 30) . For collagen content, sections were stained with Sirius red 3BA in saturated picric acid solution (Sigma) and quantified with an image analysis system (Leica Q500) (29, 30) .
Tissue Protein Analysis. Cardiac tissue FLT3 ligand expression was measured by using the ELISA kit (BD Biosciences). All regions of BMT W͞W v or W͞W v mice (n ϭ 5 each), infarcted, peri-infarcted, and normal zones, were pooled, and heart protein concentrations were measured and compared.
Statistical Analysis. Student t tests were used to compare samples. ANOVA with Newman-Keul subgroup testing were used when multiple groups were compared. Values are expressed as mean Ϯ SEM, with P Ͻ 0.05 considered significant.
